CDC committee to decide on recommendation for J&J vaccine today

(Photograph by lechatnoir/Getty Pictures)

The Centers for Disease Handle and Avoidance Advisory Committee on Immunization Procedures is predicted to vote right now on its advice for use of the Johnson & Johnson vaccine.

The committee fulfills from eleven a.m. to 5 p.m. right now in a conference open to the general public by weblink, with a 50 percent hour on the agenda open for general public comment.

Use of the Johnson & Johnson vaccine is currently on pause in all 50 states primarily based on the former advice of the committee. 6 women of all ages produced blood clots six to 13 times after obtaining the vaccine.

The CDC released an investigation after an Oregon lady in her 50s produced a blood clot and died within two months of obtaining the Johnson & Johnson COVID-19 vaccine, according to OPD. There has still to be a perseverance that the vaccine caused her death.

Present-day conference includes a hazard/advantage assessment of use of the vaccine. J&J’s chief medical officer and the world wide head of Janssen study and advancement will show up at, according to the day’s agenda.


A source has informed CBS News that the Centers for Disease Handle and Avoidance and the Meals and Drug Administration are leaning towards resuming use of the Johnson & Johnson vaccine with a warning about blood clots.

Nevertheless, it’s use is coming at a tipping point in which vaccine source will shortly outstrip demand from customers in the United States thanks to vaccine hesitancy on the component of persons who have still to get a shot.

THE Greater Development

A lot more than six.8 million doses of the J&J vaccine have been administered.

These adverse events show up to be exceptionally rare, according to Dr. Anne Schuchat, Principal Deputy Director of the CDC, and Dr. Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Analysis. 

On April 13, the advisory committee recommended pausing the vaccine as it reviewed the info of the adverse events.

Twitter: @SusanJMorse
Email the writer: [email protected]